Feel Free Herbal Tonic

Botanical Elixir • Kratom & Kava Blend

Lawsuit Risk: High Undisclosed Dependency
Supplement Facts
Serving Size: 1 Bottle (59 mL / 2 fl oz) Servings Per Container: 1
Amount Per Serving % Daily Value*
Calories: 25 Total Carb: 4g
Proprietary Botanical Blend 850 mg †
Kratom Leaf Extract (Mitragyna speciosa) 35 mg Mitragynine
• 7-Hydroxymitragynine fraction 1.2% total alkaloid
Kava Root Extract (Piper methysticum) 250 mg Kavalactones
* Percent Daily Values based on 2,000 cal diet. † Daily Value not established.
MANDATORY STATUTORY WARNING:
MISSING ADDICTION DISCLOSURE. Arizona AG & KCPA statutes require conspicuous warning that Mitragyna speciosa has psychoactive, habit-forming opioid receptor agonist potential.

Regulatory Findings & Statutory Violations 4 Critical Issues

Audit ID: KCPA-2026-AZ

The Arizona AG Botanic Tonics Precedent

On Sept 23, Arizona Attorney General Kris Mayes filed a landmark civil enforcement suit against Botanic Tonics (makers of 'Feel Free'), asserting that marketing psychoactive kratom elixirs as innocent "clean energy" or caffeine substitutes violates the Arizona Consumer Fraud Act.

  • Deceptive Framing: Concealing that mitragynine acts as a partial mu-opioid agonist while advertising clean alertness.
  • Omission of Addiction: Failing to clearly disclose physical tolerance, dependence, and severe withdrawal risks.
  • Aggressive Retail Access: Selling alongside ordinary soda and kombucha without mandatory 21+ age verification.

Kratom Consumer Protection Act (KCPA) Rules

States including Utah, Georgia, Arizona, Florida, and Nevada have enacted KCPA statutes establishing rigorous formulation and labeling baselines:

  • 7-OH Cap: 7-Hydroxymitragynine fraction must not exceed 1.0% to 2.0% of total alkaloids (banning synthetic spiking).
  • No Synthetic Alkaloids: Prohibits non-natural chemical enhancement or synthetic analogues.
  • Lab Certificate (COA): Mandatory scannable QR code to third-party batch testing for heavy metals and purity.
  • Clear Dosage Ceiling: Explicit recommendation for maximum daily serving sizes on packaging.

Kava + Kratom Potentiation Risks

Combining Piper methysticum (kava) and Mitragyna speciosa (kratom) creates synergistic CNS depression and metabolic interactions that amplify regulatory liability:

  • Cytochrome P450 Inhibition: Kavalactones inhibit CYP2D6 and CYP3A4, slowing liver clearance of mitragynine and increasing serum levels.
  • Enhanced Impairment: Simultaneous GABAergic sedation and opioid receptor stimulation impairs driving and motor control.
  • FDA Warning Letters: The FDA repeatedly cites dual botanical formulations for unapproved new drug claims when marketed for anxiety or detox.
Enjoy this tool? Build your own with Super